These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16025888)

  • 1. [Preventing type 2 diabetes complications: from evidence-based recommendations to patient-based reality].
    Beer S; Kunz GA; Ruiz J
    Rev Med Suisse; 2005 Jun; 1(22):1492-8. PubMed ID: 16025888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventing cardiovascular disease in type 2 diabetes. From evidence based medicine to patient based reality].
    Arnold-Kunz G; Ruiz J
    Rev Med Suisse; 2007 Jun; 3(114):1456-8, 1460-2. PubMed ID: 17639667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular complications of diabetes. Nursing assessment and intervention.
    Hernandez D
    Am J Nurs; 1998 Jun; 98(6):26-31; quiz 31-2. PubMed ID: 9629081
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of microvascular and macrovascular complications in diabetes mellitus.
    Maji D
    J Indian Med Assoc; 2004 Aug; 102(8):426, 428, 430 passim. PubMed ID: 15719805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.
    Krentz AJ; Clough G; Byrne CD
    Diabetes Obes Metab; 2007 Nov; 9(6):781-91. PubMed ID: 17924862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards of medical care in diabetes.
    American Diabetes Association
    Diabetes Care; 2005 Jan; 28 Suppl 1():S4-S36. PubMed ID: 15618112
    [No Abstract]   [Full Text] [Related]  

  • 8. [Japan Diabetes Complications Study (JDCS)].
    Sone H; Yamada N
    Nihon Rinsho; 2010 May; 68(5):865-71. PubMed ID: 20446585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How Germany manages it's diabetic patients].
    Einecke D
    MMW Fortschr Med; 1999 Oct; 141(42):4-5. PubMed ID: 10912093
    [No Abstract]   [Full Text] [Related]  

  • 12. The folly of population screening for type 2 diabetes.
    Marshall KG
    CMAJ; 1999 Jun; 160(11):1592-3. PubMed ID: 10374003
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Aiming for the stars'--GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews.
    Fhärm E; Rolandsson O; Johansson EE
    Fam Pract; 2009 Apr; 26(2):109-14. PubMed ID: 19208737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Will the theory of metabolic memory change our therapeutic strategies in the face of type 2 diabetes?].
    Ruiz J; Egli M
    Rev Med Suisse; 2005 Jun; 1(22):1485-6, 1488-90. PubMed ID: 16025887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.
    Athyros VG; Hatzitolios A; Karagiannis A; Didangelos TP; Iliadis F; Dolgyras S; Vosnakidis T; Vasiliadis P; Malias I; Tziomalos K; Samouilidou M; Mikhailidis DP;
    Curr Med Res Opin; 2009 Aug; 25(8):1931-40. PubMed ID: 19558210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing diabetic complications: a primary care perspective.
    Zimmet P
    Diabetes Res Clin Pract; 2009 May; 84(2):107-16. PubMed ID: 19278746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cardiologist view of vascular disease in diabetes.
    Lockhart CJ; Hamilton PK; McVeigh KA; McVeigh GE
    Diabetes Obes Metab; 2008 Apr; 10(4):279-92. PubMed ID: 17941877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular prevention in patients with diabetes and prediabetes.
    Anselmino M; Gohlke H; Mellbin L; Rydén L
    Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care.
    Feig DS; Palda VA; Lipscombe L;
    CMAJ; 2005 Jan; 172(2):177-80. PubMed ID: 15655234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.